Kowalsky Matthew Paul
SEC insider (Form 3/4/5 filer). CIK 0001705824. Chief Legal Officer at ENANTA PHARMACEUTICALS INC (ENTA). 5 reported Form 4/5 transactions since Sep 2024; latest on Feb 12, 2026. Located in WATERTOWN, MA.
Companies Kowalsky Matthew Paul has filed insider reports for
- ENANTA PHARMACEUTICALS INC (ENTA): Officer, Chief Legal Officer
Kowalsky Matthew Paul
CIK: 0001705824
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ENANTA PHARMACEUTICALS INC
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Feb 12, 2026ENTA
ENANTA PHARMACEUTICALS INC
AwardDirect1.3K shares- - Feb 12, 2026ENTA
ENANTA PHARMACEUTICALS INC
AwardDirect4.2K shares- - Feb 12, 2026ENTA
ENANTA PHARMACEUTICALS INC
Tax PaymentDirect1.9K shares at avg. $14.25$27K - Nov 25, 2025ENTA
ENANTA PHARMACEUTICALS INC
AwardDirectStock Option (right to buy)
90K shares- - Nov 27, 2024ENTA
ENANTA PHARMACEUTICALS INC
AwardDirectStock Option (right to buy)
75K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 12, 2026 | ENTA ENANTA PHARMACEUTICALS INC | Award | 1,318 | - | $0 | Direct |
| Feb 12, 2026 | ENTA ENANTA PHARMACEUTICALS INC | Award | 4,175 | - | $0 | Direct |
| Feb 12, 2026 | ENTA ENANTA PHARMACEUTICALS INC | Tax Payment | 1,902 | $14.25 | $27,104 | Direct |
| Nov 25, 2025 | ENTA ENANTA PHARMACEUTICALS INC | Award Stock Option (right to buy) | 90,000 | - | - | Direct |
| Nov 27, 2024 | ENTA ENANTA PHARMACEUTICALS INC | Award Stock Option (right to buy) | 75,000 | - | - | Direct |
1-5 of 5 transactions